|
|
Post by harryx1 on Aug 21, 2019 14:32:50 GMT -5
|
|
paul
Researcher
Posts: 134
|
Post by paul on Aug 21, 2019 15:06:05 GMT -5
It says "If the measurement decreases by 25 percent or more, they must stop using inhaled insulin.” Where does the afrezza literature specify 25 percent as the cutoff number?
|
|
|
|
Post by letitride on Aug 24, 2019 19:48:07 GMT -5
It says "If the measurement decreases by 25 percent or more, they must stop using inhaled insulin.” Where does the afrezza literature specify 25 percent as the cutoff number? I think if I lost 25% of my lung function in a year Id be doing alot more than stopping my afrezza use. Id be looking hard at 10% |
|
|
|
Post by mango on Aug 24, 2019 20:57:14 GMT -5
The article states,
Inhaled insulin isn’t an option for everyone. Those who shouldn’t use inhaled insulin include:
• Anyone with a history of asthma, including exercise-induced asthma
• Smokers (must be smoke-free for six months prior to starting Afrezza)
• Anyone with lung disease: asthma, bronchitis, COPD
• Anyone already on any inhaled medication
• Children under 18
The only contraindications listed for AFREZZA in the FDA label are:
• During episodes of hypoglycemia
• Chronic lung disease, such as asthma, or chronic obstructive pulmonary disease
• Hypersensitivity to regular human insulin or any of the AFREZZA excipients
Where did the author obtain the information highlighted in bold?
|
|
|
|
Post by mango on Aug 24, 2019 21:02:08 GMT -5
It says "If the measurement decreases by 25 percent or more, they must stop using inhaled insulin.” Where does the afrezza literature specify 25 percent as the cutoff number? The FDA label says, In patients who have a decline of ≥ 20% in FEV1 from baseline, consider discontinuing AFREZZA. |
|
|
|
Post by joeypotsandpans on Aug 29, 2019 11:18:07 GMT -5
|
|
